GURUFOCUS.COM » STOCK LIST » Healthcare » Medical Devices & Instruments » Elekta AB (FRA:EJXB) » Definitions » Net Income Including Noncontrolling Interests

Elekta AB (FRA:EJXB) Net Income Including Noncontrolling Interests : €125 Mil (TTM As of Jan. 2024)


View and export this data going back to . Start your Free Trial

What is Elekta AB Net Income Including Noncontrolling Interests?

Net Income Including Noncontrolling Interests is the net income of the group after the adjustment of all expenses and benefit. It includes the net income (loss) attributable to noncontrolling and redeemable noncontrolling interests and the net income (loss) attributable to the company.

Elekta AB's Net Income Including Noncontrolling Interests for the three months ended in Jan. 2024 was €27 Mil. Its Net Income Including Noncontrolling Interests for the trailing twelve months (TTM) ended in Jan. 2024 was €125 Mil.

Elekta AB Net Income Including Noncontrolling Interests Historical Data

The historical data trend for Elekta AB's Net Income Including Noncontrolling Interests can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Elekta AB Net Income Including Noncontrolling Interests Chart

Elekta AB Annual Data
Trend Apr14 Apr15 Apr16 Apr17 Apr18 Apr19 Apr20 Apr21 Apr22 Apr23
Net Income Including Noncontrolling Interests
Get a 7-Day Free Trial Premium Member Only Premium Member Only 114.30 99.57 123.25 112.09 83.19

Elekta AB Quarterly Data
Apr19 Jul19 Oct19 Jan20 Apr20 Jul20 Oct20 Jan21 Apr21 Jul21 Oct21 Jan22 Apr22 Jul22 Oct22 Jan23 Apr23 Jul23 Oct23 Jan24
Net Income Including Noncontrolling Interests Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 19.28 48.21 20.49 29.55 27.03

Elekta AB Net Income Including Noncontrolling Interests Calculation

Net Income Including Noncontrolling Interests is the net income of the group after the adjustment of all expenses and benefit. It includes the net income (loss) attributable to noncontrolling and redeemable noncontrolling interests and the net income (loss) attributable to the company.

Net Income Including Noncontrolling Interests for the trailing twelve months (TTM) ended in Jan. 2024 adds up the quarterly data reported by the company within the most recent 12 months, which was €125 Mil.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Elekta AB Net Income Including Noncontrolling Interests Related Terms

Thank you for viewing the detailed overview of Elekta AB's Net Income Including Noncontrolling Interests provided by GuruFocus.com. Please click on the following links to see related term pages.

Elekta AB (FRA:EJXB) Business Description

Industry
GURUFOCUS.COM » STOCK LIST » Healthcare » Medical Devices & Instruments » Elekta AB (FRA:EJXB) » Definitions » Net Income Including Noncontrolling Interests
Comparable Companies
OSTO:BONEX OSTO:BIOT OSTO:ALIF B OSTO:SYNSAM OSTO:TDVOX OSTO:ADDV A OSTO:DOXA XSAT:BPCINS OSTO:QLINEA OSTO:ORTI A ISRG XPAR:EL BDX TSE:7741 XSWX:ALC OCSE:COLO B RMD WST XPAR:DIM TSE:4543
Traded in Other Exchanges
EKTAY:USA EKTAF:USA EKTA B:Sweden EKTAB:Mexico EKTABs:UK 0O5H:UK
Address
Kungstensgatan 18, Box 7593, Stockholm, SWE, SE-103 93
Website
https://www.elekta.com
Sweden-based Elekta develops, manufactures, and distributes treatment planning systems for neurosurgery and radiotherapy, including stereotactic radiosurgery and brachytherapy. The company's installed base of more than 5,000 linear accelerators, GammaKnife and Unity platforms, and software is used in more than 6,000 hospitals globally. The company's sales are evenly distributed across geographies, with North and South America accounting for 31%; Europe, the Middle East, and Africa accounting for 35%; and Asia-Pacific contributing the remainder.

Elekta AB (FRA:EJXB) Headlines

No Headlines